Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 May 12:2023.04.27.23289228.
doi: 10.1101/2023.04.27.23289228.

Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design

Rachel Gross  1 Tanayott Thaweethai  2 Erika B Rosenzweig  3 James Chan  2 Lori B Chibnik  2 Mine S Cicek  4 Amy J Elliott  5 Valerie J Flaherman  6 Andrea S Foulkes  2 Margot Gage Witvliet  7 Richard Gallagher  8 Maria Laura Gennaro  9 Terry L Jernigan  10 Elizabeth W Karlson  11 Stuart D Katz  12 Patricia A Kinser  13 Lawrence C Kleinman  14 Michelle F Lamendola-Essel  12 Joshua D Milner  15 Sindhu Mohandas  16 Praveen C Mudumbi  17 Jane W Newburger  18 Kyung E Rhee  19 Amy L Salisbury  20 Jessica N Snowden  21 Cheryl R Stein  22 Melissa S Stockwell  23 Kelan G Tantisira  24 Moriah E Thomason  8 Dongngan T Truong  25 David Warburton  26 John C Wood  27 Shifa Ahmed  2 Almary Akerlundh  28 Akram N Alshawabkeh  29 Brett R Anderson  30 Judy L Aschner  31 Andrew M Atz  32 Robin L Aupperle  33 Fiona C Baker  34 Venkataraman Balaraman  35 Dithi Banerjee  36 Deanna M Barch  37 Arielle Baskin-Sommers  38 Sultana Bhuiyan  12 Marie-Abele C Bind  2 Amanda L Bogie  39 Natalie C Buchbinder  40 Elliott Bueler  12 Hülya Bükülmez  41 B J Casey  42 Linda Chang  43 Duncan B Clark  44 Rebecca G Clifton  45 Katharine N Clouser  46 Lesley Cottrell  47 Kelly Cowan  48 Viren D'Sa  49 Mirella Dapretto  50 Soham Dasgupta  51 Walter Dehority  52 Kirsten B Dummer  53 Matthew D Elias  54 Shari Esquenazi-Karonika  17 Danielle N Evans  55 E Vincent S Faustino  56 Alexander G Fiks  57 Daniel Forsha  58 John J Foxe  59 Naomi P Friedman  60 Greta Fry  61 Sunanda Gaur  62 Dylan G Gee  38 Kevin M Gray  63 Ashraf S Harahsheh  64 Andrew C Heath  65 Mary M Heitzeg  66 Christina M Hester  67 Sophia Hill  12 Laura Hobart-Porter  68 Travis K F Hong  35 Carol R Horowitz  69 Daniel S Hsia  70 Matthew Huentelman  71 Kathy D Hummel  72 William G Iacono  73 Katherine Irby  74 Joanna Jacobus  75 Vanessa L Jacoby  76 Pei-Ni Jone  77 David C Kaelber  78 Tyler J Kasmarcak  79 Matthew J Kluko  56 Jessica S Kosut  35 Angela R Laird  80 Jeremy Landeo-Gutierrez  81 Sean M Lang  82 Christine L Larson  83 Peter Paul C Lim  84 Krista M Lisdahl  83 Brian W McCrindle  85 Russell J McCulloh  86 Alan L Mendelsohn  87 Torri D Metz  88 Lerraughn M Morgan  89 Eva M Müller-Oehring  34 Erica R Nahin  12 Michael C Neale  90 Manette Ness-Cochinwala  62 Sheila M Nolan  91 Carlos R Oliveira  92 Matthew E Oster  93 R Mark Payne  94 Hengameh Raissy  95 Isabelle G Randall  12 Suchitra Rao  96 Harrison T Reeder  2 Johana M Rosas  12 Mark W Russell  97 Arash A Sabati  98 Yamuna Sanil  99 Alice I Sato  100 Michael S Schechter  101 Rangaraj Selvarangan  36 Divya Shakti  102 Kavita Sharma  103 Lindsay M Squeglia  63 Michelle D Stevenson  104 Jacqueline Szmuszkovicz  105 Maria M Talavera-Barber  106 Ronald J Teufel 2nd  32 Deepika Thacker  107 Mmekom M Udosen  108 Megan R Warner  28 Sara E Watson  104 Alan Werzberger  15 Jordan C Weyer  109 Marion J Wood  17 H Shonna Yin  110 William T Zempsky  111 Emily Zimmerman  112 Benard P Dreyer  1
Affiliations

Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design

Rachel Gross et al. medRxiv. .

Update in

  • Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.
    Horwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, Hess R, Hodder SL, Jacoby VL, Jordan MR, Krishnan JA, Laiyemo AO, Metz TD, Nichols L, Patzer RE, Sekar A, Singer NG, Stiles LE, Taylor BS, Ahmed S, Algren HA, Anglin K, Aponte-Soto L, Ashktorab H, Bassett IV, Bedi B, Bhadelia N, Bime C, Bind MC, Black LJ, Blomkalns AL, Brim H, Castro M, Chan J, Charney AW, Chen BK, Chen LQ, Chen P, Chestek D, Chibnik LB, Chow DC, Chu HY, Clifton RG, Collins S, Costantine MM, Cribbs SK, Deeks SG, Dickinson JD, Donohue SE, Durstenfeld MS, Emery IF, Erlandson KM, Facelli JC, Farah-Abraham R, Finn AV, Fischer MS, Flaherman VJ, Fleurimont J, Fonseca V, Gallagher EJ, Gander JC, Gennaro ML, Gibson KS, Go M, Goodman SN, Granger JP, Greenway FL, Hafner JW, Han JE, Harkins MS, Hauser KSP, Heath JR, Hernandez CR, Ho O, Hoffman MK, Hoover SE, Horowitz CR, Hsu H, Hsue PY, Hughes BL, Jagannathan P, James JA, John J, Jolley S, Judd SE, Juskowich JJ, Kanjilal DG, Karlson EW, Katz SD, Kelly JD, Kelly SW, Kim AY, Kirwan JP, Knox KS, Kumar A, Lamendola-Essel MF, Lanca M, Lee-Lannotti JK, Lefebvre RC, Levy BD, Lin JY, Logarbo BP Jr, Logue JK, Longo MT, Luciano CA, Lutrick K, Malakooti SK, Ma… See abstract for full author list ➔ Horwitz LI, et al. PLoS One. 2023 Jun 23;18(6):e0286297. doi: 10.1371/journal.pone.0286297. eCollection 2023. PLoS One. 2023. PMID: 37352211 Free PMC article.

Abstract

Importance: The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae of SARS-CoV-2 [PASC] or "Long COVID") in children and young adults remain unknown. Studies must address the urgent need to define PASC, its mechanisms, and potential treatment targets in children and young adults.

Observations: We describe the protocol for the Pediatric Observational Cohort Study of the NIH's RE searching COV ID to E nhance R ecovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study of caregiver-child pairs (birth through 17 years) and young adults (18 through 25 years), recruited from more than 100 sites across the US. This report focuses on two of five cohorts that comprise RECOVER-Pediatrics: 1) a de novo RECOVER prospective cohort of children and young adults with and without previous or current infection; and 2) an extant cohort derived from the Adolescent Brain Cognitive Development (ABCD) study ( n =10,000). The de novo cohort incorporates three tiers of data collection: 1) remote baseline assessments (Tier 1, n=6000); 2) longitudinal follow-up for up to 4 years (Tier 2, n=6000); and 3) a subset of participants, primarily the most severely affected by PASC, who will undergo deep phenotyping to explore PASC pathophysiology (Tier 3, n=600). Youth enrolled in the ABCD study participate in Tier 1. The pediatric protocol was developed as a collaborative partnership of investigators, patients, researchers, clinicians, community partners, and federal partners, intentionally promoting inclusivity and diversity. The protocol is adaptive to facilitate responses to emerging science.

Conclusions and relevance: RECOVER-Pediatrics seeks to characterize the clinical course, underlying mechanisms, and long-term effects of PASC from birth through 25 years old. RECOVER-Pediatrics is designed to elucidate the epidemiology, four-year clinical course, and sociodemographic correlates of pediatric PASC. The data and biosamples will allow examination of mechanistic hypotheses and biomarkers, thus providing insights into potential therapeutic interventions.

Clinical trialsgov identifier: Clinical Trial Registration: http://www.clinicaltrials.gov . Unique identifier: NCT05172011.

PubMed Disclaimer

Conflict of interest statement

Competing interests

Brett Anderson reported receiving direct support for work not related to RECOVER work/publications from Genentech and the National Institute of Allergy and Immunology.

Walter Dehority reported receiving grant support from Merck and participating in research for the Moderna COVID-19 pediatric vaccine trial and the Pfizer Paxlovid trial.

Alex Fiks reported receiving support from NJM insurance and personal consulting fees not related to this paper from Rutgers University and the American Academy of Pediatrics.

Ashraf Harahsheh reported serving as a scientific advisory board member unrelated to this paper for OP2 DRUGS.

Lawrence Kleinman reported serving as an unpaid member of the Board of Directors for the DARTNet Institute, as a principle investigator at Quality Matters, Inc., and as the Vice Chair for the Borough of Metuchen Board of Health. Dr. Kleinman also reported grant support for work not related to RECOVER work/publications from NIH, HRSA, and the Robert Wood Johnson Foundation. Dr. Kleinman also reported minority individual stock ownership in Apple Computer, Sanofi SA, Experion, GlaxoSmithKline, Magyar Bank, Regeneron Pharmaceuticals, JP Morgan Chase, and Amgen Inc.

Torri Metz reported participating as a Principle Investigator in the medical advisory board for the planning of a Pfizer clinical trial of SARS-CoV-2 vaccination in pregnancy. She is also a principle investigator for a Pfizer study evaluating the pharmacokinetics of Paxlovid in pregnant people with COVID-19.

Joshua Milner reported serving as a member of the Scientific Advisory Board for Blueprint Medicines, in a capacity unrelated to RECOVER work/publications.

Figures

Fig 1:
Fig 1:
Overview of RECOVER-Pediatrics (de novo and ABCD cohorts).

References

    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–46. Epub 20230113. doi: 10.1038/s41579-022-00846-2. - DOI - PMC - PubMed
    1. World Health Organization. WHO Coronavirus (COVID-19) dashboard 2023 2023. Available from: https://covid19.who.int/.
    1. Zimmermann P, Pittet LF, Curtis N. How common is Long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482–e7. doi: 10.1097/inf.0000000000003328. - DOI - PMC - PubMed
    1. Kompaniyets L, Bull-Otterson L, Boehmer TK, Baca S, Alvarez P, Hong K, et al. Post-COVID-19 symptoms and conditions among children and adolescents - United States, March 1, 2020-January 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(31):993–9. Epub 20220805. doi: 10.15585/mmwr.mm7131a3. - DOI - PMC - PubMed
    1. Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597–607. Epub 20220109. doi: 10.1007/s00431-021-04345-z. - DOI - PMC - PubMed

Publication types

Associated data